Literature DB >> 24748904

Mucous membranepemphigoid in two half-sisters. The potential roles of autoantibodies to β4 integrin subunits and HLA-DQβ1*0301.

Diogo Fabris Rabelo1, Tegan Nguyen1, Brooke Ann Caufield2, Abdul Razzaque Ahmed1.   

Abstract

BACKGROUND: Mucous membrane pemphigoid (MMP) is a subepithelial autoimmune mucocutaneous disease. It most frequently affects the oral mucosa, followed by ocular and nasal mucosa, nasopharyngeal, anogenital, skin, laryngeal and esophageal mucosa. MAIN OBSERVATION: Two half-sisters developed mucous membrane pemphigoid at approximately the same age. The older sister presented with primarily mucosal disease, while the younger had a more cutaneous disease. The histopathology demonstrated a subepithelial blister and direct immunofluorescence showed deposition of IgG and C3 at the basement membrane zone of perilesional tissues in both sisters. Antibodies to human β4 integrin were present in the sera of both patients and correlated with disease activity. Both sisters carried the same HLADQβ1* 0301 allele.
CONCLUSIONS: This is the first case of mucous membrane pemphigoid occurring in two half-sisters. Perhaps, it is the low incidence of mucous membrane pemphigoid that may account for the lack of reports on familial cases of the disease.

Entities:  

Keywords:  IVIG; basement membrane zone; dapsone; dysphagia; family; pemphigoid; tacrolimus

Year:  2014        PMID: 24748904      PMCID: PMC3989090          DOI: 10.3315/jdcr.2014.1162

Source DB:  PubMed          Journal:  J Dermatol Case Rep        ISSN: 1898-7249


  19 in total

1.  Identification of ocular cicatricial pemphigoid antibody binding site(s) in human beta4 integrin.

Authors:  S Kumari; K C Bhol; R K Simmons; M S Razzaque; E Letko; C S Foster; A Razzaque Ahmed; A R Ahmed
Journal:  Invest Ophthalmol Vis Sci       Date:  2001-02       Impact factor: 4.799

Review 2.  The first international consensus on mucous membrane pemphigoid: definition, diagnostic criteria, pathogenic factors, medical treatment, and prognostic indicators.

Authors:  Lawrence S Chan; A Razzaque Ahmed; Grant J Anhalt; Wolfgang Bernauer; Kevin D Cooper; Mark J Elder; Jo-David Fine; C Stephen Foster; Reza Ghohestani; Takashi Hashimoto; Thanh Hoang-Xuan; Gudula Kirtschig; Neil J Korman; Susan Lightman; Francina Lozada-Nur; M Peter Marinkovich; Bartly J Mondino; Catherine Prost-Squarcioni; Roy S Rogers; Jane F Setterfield; Dennis P West; Fenella Wojnarowska; David T Woodley; Kim B Yancey; Detlef Zillikens; John J Zone
Journal:  Arch Dermatol       Date:  2002-03

Review 3.  Use of intravenous immunoglobulin therapy in autoimmune blistering diseases.

Authors:  A Razzaque Ahmed
Journal:  Int Immunopharmacol       Date:  2005-12-13       Impact factor: 4.932

Review 4.  Pemphigoid diseases.

Authors:  Enno Schmidt; Detlef Zillikens
Journal:  Lancet       Date:  2012-12-11       Impact factor: 79.321

5.  The autoantibodies to alpha 6 beta 4 integrin of patients affected by ocular cicatricial pemphigoid recognize predominantly epitopes within the large cytoplasmic domain of human beta 4.

Authors:  K C Bhol; M J Dans; R K Simmons; C S Foster; F G Giancotti; A R Ahmed
Journal:  J Immunol       Date:  2000-09-01       Impact factor: 5.422

6.  IgG autoantibodies in patients with anti-epiligrin cicatricial pemphigoid recognize the G domain of the laminin 5 alpha-subunit.

Authors:  Z Lazarova; C Yee; J Lazar; K B Yancey
Journal:  Clin Immunol       Date:  2001-10       Impact factor: 3.969

7.  Association of DQw7 (DQB1*0301) with ocular cicatricial pemphigoid.

Authors:  A R Ahmed; S Foster; M Zaltas; G Notani; Z Awdeh; C A Alper; E J Yunis
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-15       Impact factor: 11.205

Review 8.  Efficacy of dapsone in the treatment of pemphigus and pemphigoid: analysis of current data.

Authors:  Hakan M Gürcan; A Razzaque Ahmed
Journal:  Am J Clin Dermatol       Date:  2009       Impact factor: 7.403

Review 9.  Consensus statement on the use of intravenous immunoglobulin therapy in the treatment of autoimmune mucocutaneous blistering diseases.

Authors:  A Razzaque Ahmed; Mark V Dahl
Journal:  Arch Dermatol       Date:  2003-08

Review 10.  Mucous membrane pemphigoid.

Authors:  Hong-Hui Xu; Victoria P Werth; Ernesta Parisi; Thomas P Sollecito
Journal:  Dent Clin North Am       Date:  2013-08-15
View more
  2 in total

Review 1.  The Immunogenetics of Autoimmune Blistering Diseases.

Authors:  Diana Kneiber; Eric H Kowalski; Kyle T Amber
Journal:  Adv Exp Med Biol       Date:  2022       Impact factor: 2.622

Review 2.  Ocular Mucous Membrane Pemphigoid: Current State of Pathophysiology, Diagnostics and Treatment.

Authors:  Panagiotis Georgoudis; Francesco Sabatino; Nora Szentmary; Sotiria Palioura; Eszter Fodor; Samer Hamada; Hendrik P N Scholl; Zisis Gatzioufas
Journal:  Ophthalmol Ther       Date:  2019-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.